Immuneering (IMRX) Shares Issued (2021 - 2026)

Immuneering's Shares Issued history runs 6 years deep, the most recent figure standing at $170325.0 for Q1 2026.

• In Q1 2026, Shares Issued rose 27.21% year-over-year to $170325.0; the TTM figure through Mar 2026 stood at $1.3 million (down 67.68% YoY), while the FY2025 annual figure was $368532.0, down 1.63% from the prior year.
• Shares Issued was $170325.0 for Q1 2026 at Immuneering, up from -$53378.0 in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $4.2 million in Q3 2024 to a low of -$732458.0 in Q2 2024.
• Historically, Shares Issued has averaged $419602.2 across 5 years, with a median of $133892.0 in 2025.
• Biggest YoY gain for Shares Issued was 1068.89% in 2023; the steepest drop was 1138.06% in 2023.
• A 5-year view of Shares Issued shows it stood at $42098.0 in 2022, then plunged by 1138.06% to -$437003.0 in 2023, then soared by 185.73% to $374652.0 in 2024, then sank by 114.25% to -$53378.0 in 2025, then soared by 419.09% to $170325.0 in 2026.
• The last three Shares Issued figures came in at $170325.0 (Q1 2026), -$53378.0 (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.